News

The 3rd Annual Meeting of IMMUTOL in Siena

843 420 IMMUTOL

The 3rd Annual Meeting of IMMUTOL was hosted and organised by INN-Acta in Siena, Italy, between 20th and 21st of May 2026. The meeting provided a valuable opportunity for in-person discussions, sharing results, and planning future activities during dedicated brainstorming sessions. It also served to prepare for the reporting and review meeting. A significant aspect of the event was a…

read more

IGTP represented IMMUTOL at the SCI 2026

315 236 IMMUTOL

Jana Willemyns (IGTP) participated in the 46th Congress of the Spanish Society of Immunology (Sociedad Española de Inmunología, SEI), which took place in Cordoba, Spain, from April 16th to 18th, 2026. She presented her work in poster entitled: Assessing the in vivo efficacy of IL-10 engineered Vitamin D3-tolerogenic dendritic cells in the experimental autoimmune encephalomyelitis…

read more

NVVI (Dutch Society for Immunology) 2025

432 576 IMMUTOL

Liubov Babii & Daniëlle ter Braake from SQ presented a poster at the NVVI conference in 2025, Noordwijkerhout, The Netherlands. The poster was focused on how VitD3DCIL-10 modulate B cell responses in a T cell-dependent manner. At the NVVI, Immunologists from all over the Netherlands come together to discuss immunology research, and therefore, this provides…

read more

Sanquin Science Day

434 579 IMMUTOL

Liubov Babii & Daniëlle ter Braake from SQ presented a poster at the Sanquin Science Day to show their data on the T cell-independent effect of VitD3DCIL-10 on B cells. The meeting was an excellent opportunity to discuss the findings, plans and to gather new insights into possible techniques SQ already has in-house.

read more

SCI 2025

258 146 IMMUTOL

Alex Agúndez Moreno and Eva Martínez-Cáceres from IGTP represented IMMUTOL at the XIX Congress of the Catalan Society of Immunology, SCI 2025, 20-21st November 2025, Barcelona, Spain. LINK: https://sci.cat/?p=page/html/detallactivitat/id/27307/codi_entitat/022/tipus_entitat/s

read more

SRI represented IMMUTOL at ISPORE EUROPE 2025

756 942 IMMUTOL

Attila Imre (SRI) presented a poster entitled: Early stage health economic evaluation of IMMUTOL gene Therapy for relapsing/remitting Multiple Sclerosis in the Netherlands at ISPOR Europe 2025, 9-12 November 2025, Glasgow, Scotland, UK. Link to event page Poto: SRI ISPORE 2025

read more

FOCIS 2025

534 400 IMMUTOL

Alex Agundez-Moreno and Eva Martínez-Cáceres from the IGTP team represented IMMUTOL at the meeting of the Federation of Clinical Immunology Societies (FOCIS) 2025, Rouen, France, 20-24th October 2025. Eva gave a talk entitled: Cell-based tolerogenic therapies in autoimmune diseases and Alex presented a poster entitled: Immune monitoring antigen-specific autoreactive T-cell responses in a cohort of…

read more

IMMUTOL at ECTRIMS 2025

1024 768 IMMUTOL

41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) was held between September 24th–26th in Barcelona, Spain. IMMUTOL was represented by team members from the Institut de Recerca Germans Trias i Pujol (IGTP): Alex Agúndez Moreno and Cristina Ramo Tello, along with our collaborator, the European Multiple Sclerosis Platform (EMSP).

read more

IQS at the 2nd Barcelona Blood–Brain Barrier (B4) Conference

541 722 IMMUTOL

Sara presented her work on the development of an advanced cell therapy based on antigen-specific tolerogenic dendritic cells (TolDCs) to re-establish immune tolerance in immune-mediated diseases. Event website

read more

Published paper authored by the SRI team!

512 512 IMMUTOL

The paper recently published in the British Journal of Clinical Pharmacology is entitled: Early-stage health technology assessment of a curative gene therapy for multiple sclerosis. Link to the article: http://doi.org/10.1002/bcp.70204 As indicated in the paper abstract, the authors conclude that ‘IMMUTOL gene therapy shows promising cost-effectiveness at a value-based price up to approximately €500 000, contingent on achieving curative clinical efficacy.…

read more